Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Send an inquiry form See our COA process Research applications Skin- and extracellular-matrix research models Copper-peptide (GHK-Cu) signalling research Angiogenesis and cytoprotection research Multi-peptide comparative research models Listed for research context only Certiva makes no medical, therapeutic, or dosing claims
Further reading [edit] al
Contact and Modifications QUESTIONS: For legitimate business inquiries regarding our products or policies, contact us at [email protected]
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Tracking your progress can help maintain motivation during slower phases
Eksperimental'naia i klinicheskaia farmakologiia, 72(4), 68
US$ 21.51
US$ 25.67
US$ 22.48
US$ 26.67
US$ 22.99
US$ 29.72
